135 related articles for article (PubMed ID: 26051455)
1. Serum biomarkers may help predict successful misoprostol management of early pregnancy failure.
Schreiber CA; Ratcliffe SJ; Quinley KE; Miller C; Sammel MD
Reprod Biol; 2015 Jun; 15(2):79-85. PubMed ID: 26051455
[TBL] [Abstract][Full Text] [Related]
2. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
[TBL] [Abstract][Full Text] [Related]
3. Single versus repeat doses of misoprostol for treatment of early pregnancy loss-a randomized clinical trial.
Mizrachi Y; Dekalo A; Gluck O; Miremberg H; Dafna L; Feldstein O; Weiner E; Bar J; Sagiv R
Hum Reprod; 2017 Jun; 32(6):1202-1207. PubMed ID: 28402415
[TBL] [Abstract][Full Text] [Related]
4. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
Creinin MD
Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
[TBL] [Abstract][Full Text] [Related]
5. Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure.
El-Baradie SMY; El-Said MH; Ragab WS; Elssery KM; Mahmoud M
J Obstet Gynaecol Can; 2008 Oct; 30(10):877-881. PubMed ID: 19038070
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure.
Demetroulis C; Saridogan E; Kunde D; Naftalin AA
Hum Reprod; 2001 Feb; 16(2):365-9. PubMed ID: 11157836
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
[TBL] [Abstract][Full Text] [Related]
8. Early pregnancy failure: factors affecting successful medical treatment.
Odeh M; Tendler R; Kais M; Maximovsky O; Ophir E; Bornstein J
Isr Med Assoc J; 2010 Jun; 12(6):325-8. PubMed ID: 20928983
[TBL] [Abstract][Full Text] [Related]
9. Factors related to successful misoprostol treatment for early pregnancy failure.
Creinin MD; Huang X; Westhoff C; Barnhart K; Gilles JM; Zhang J;
Obstet Gynecol; 2006 Apr; 107(4):901-7. PubMed ID: 16582130
[TBL] [Abstract][Full Text] [Related]
10. Utility of βhCG monitoring in the follow-up of medical management of miscarriage.
Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):358-365. PubMed ID: 28345139
[TBL] [Abstract][Full Text] [Related]
11. Medical management of missed abortion: a randomized clinical trial.
Wood SL; Brain PH
Obstet Gynecol; 2002 Apr; 99(4):563-6. PubMed ID: 12039111
[TBL] [Abstract][Full Text] [Related]
12. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Sun Y; Roberts TE; Ogwulu CO; Williams E; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Deb S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge F; Shahid A; Gallos ID; Horne AW; Quenby S; Coomarasamy A
Lancet; 2020 Sep; 396(10253):770-778. PubMed ID: 32853559
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal misoprostol 600 microg and 800 microg for the treatment of early pregnancy failure.
Kovavisarach E; Jamnansiri C
Int J Gynaecol Obstet; 2005 Sep; 90(3):208-12. PubMed ID: 15967450
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
15. Serum β-hCG concentration is a predictive factor for successful early medical abortion with vaginal misoprostol within 24 hours.
Kim JI; Park IY; Yim JM; Cheon JY; Yun HG; Kwon JY
Obstet Gynecol Sci; 2017 Sep; 60(5):427-432. PubMed ID: 28989918
[TBL] [Abstract][Full Text] [Related]
16. Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.
Wang M; Chen J; Ying J; Yu J; Huang B; Ren Z; Wang X; Guo Q; Wang Y; Qiu L; Yu H; Wan R
PLoS One; 2013; 8(5):e63755. PubMed ID: 23696855
[TBL] [Abstract][Full Text] [Related]
17. Experience with misoprostol in the management of missed abortion in the second trimester.
Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
[TBL] [Abstract][Full Text] [Related]
18. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
[TBL] [Abstract][Full Text] [Related]
19. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
[TBL] [Abstract][Full Text] [Related]
20. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
